n-methyl-3,4-methylenedioxyamphetamine has been researched along with 2019 Novel Coronavirus Disease in 13 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mellos, E | 1 |
| Paparrigopoulos, T | 1 |
| Boogaerts, T | 1 |
| Quireyns, M | 1 |
| De Prins, M | 1 |
| Pussig, B | 1 |
| De Loof, H | 1 |
| Matheï, C | 1 |
| Aertgeerts, B | 1 |
| Van Coppenolle, V | 1 |
| Fransen, E | 1 |
| Covaci, A | 1 |
| van Nuijs, ALN | 1 |
| Estévez-Danta, A | 1 |
| Bijlsma, L | 1 |
| Capela, R | 1 |
| Cela, R | 1 |
| Celma, A | 1 |
| Hernández, F | 1 |
| Lertxundi, U | 1 |
| Matias, J | 1 |
| Montes, R | 1 |
| Orive, G | 1 |
| Prieto, A | 1 |
| Santos, MM | 1 |
| Rodil, R | 1 |
| Quintana, JB | 1 |
| Hahn, RZ | 1 |
| Bastiani, MF | 1 |
| Lizot, LLF | 1 |
| Schneider, A | 1 |
| da Silva Moreira, IC | 1 |
| Meireles, YF | 1 |
| Viana, MF | 1 |
| do Nascimento, CA | 1 |
| Linden, R | 1 |
| Le, A | 1 |
| Wasserman, A | 1 |
| Palamar, JJ | 2 |
| Akhoundzadeh, D | 1 |
| Kamali, P | 1 |
| van den Bogaard, B | 1 |
| Gresnigt, FMJ | 1 |
| Psichoudaki, M | 1 |
| Mina, T | 1 |
| Savvidou, M | 1 |
| Mina, C | 1 |
| Michael, C | 1 |
| Fatta-Kassinos, D | 1 |
| Price, O | 2 |
| Man, N | 2 |
| Sutherland, R | 1 |
| Bruno, R | 2 |
| Dietze, P | 2 |
| Salom, C | 2 |
| Agramunt, S | 1 |
| Grigg, J | 2 |
| Degenhardt, L | 2 |
| Peacock, A | 2 |
| Luo, J | 1 |
| Bello, D | 1 |
| Pagsuyoin, S | 1 |
| Perrone, D | 1 |
| Fischer, R | 1 |
| Florek, J | 1 |
| Rousis, N | 1 |
| Bade, R | 1 |
| Romero-Sánchez, I | 1 |
| Mueller, JF | 1 |
| Thomaidis, NS | 1 |
| Thomas, KV | 1 |
| Gracia-Lor, E | 1 |
| Acosta, P | 1 |
| Lenton, S | 1 |
| Gibbs, D | 1 |
| Wilson, T | 1 |
| Chan, R | 1 |
| Thomas, N | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Substance use during the COVID-19 pandemic: What is really happening?
Topics: Adult; Benzodiazepines; Cocaine; Communicable Disease Control; COVID-19; Cross-Sectional Studies; Hu | 2022 |
12 other studies available for n-methyl-3,4-methylenedioxyamphetamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater.
Topics: Amphetamines; Belgium; Central Nervous System Stimulants; Cocaine; Communicable Disease Control; COV | 2022 |
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
Topics: Amphetamine; Cocaine; Communicable Disease Control; COVID-19; Humans; Illicit Drugs; Methamphetamine | 2022 |
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-me | 2022 |
Risky Party and Nightclub Attendance during the COVID-19 Nightlife Shutdown in New York City.
Topics: Adult; COVID-19; Dancing; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; New York Ci | 2022 |
[Impact of the COVID-19 pandemic on recreational drug intoxications].
Topics: Adolescent; Cocaine; Communicable Disease Control; COVID-19; Dronabinol; Emergency Service, Hospital | 2022 |
Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Communicable Disease Control; COVID-19; Cyprus; Humans | 2023 |
Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
Topics: Australia; Cocaine; COVID-19; Heroin; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamin | 2023 |
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town.
Topics: Amphetamine; Cocaine; COVID-19; Fentanyl; Humans; Hydrocodone; Methadone; N-Methyl-3,4-methylenediox | 2023 |
COVID-19-Related Shifts in Polysubstance Use.
Topics: Communicable Disease Control; COVID-19; Female; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Pand | 2023 |
Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
Topics: Cocaine; COVID-19; Heroin; Holidays; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; | 2023 |
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers.
Topics: Adult; COVID-19; Dancing; Electronics; Humans; Illicit Drugs; Music; N-Methyl-3,4-methylenedioxyamph | 2021 |
Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.
Topics: Australia; COVID-19; Cross-Sectional Studies; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamph | 2022 |